Department of Neurosurgery, M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Box 442, Houston, TX 77030-4009, USA.
Eur Spine J. 2012 Jan;21(1):84-92. doi: 10.1007/s00586-011-1882-7. Epub 2011 Jun 18.
Vertebral body resection to treat spine tumors necessitates reconstruction to maintain spinal stability. The durability of reconstruction may be a challenge in cancer patients as treatment with chemotherapy and/or radiation coupled with poor nutritional status may compromise bone quality. We present a series of patients who underwent implantation of an expandable titanium cage (ETC) for reconstruction after vertebral body resection for primary or metastatic spine tumors. We report the functional outcome, assess the durability of reconstruction, and describe complications associated with this procedure.
A retrospective review of patients undergoing placement of ETC after vertebrectomy for spinal tumor at our institution was performed.
From September 2001 to August 2006, 95 patients underwent implantation of an ETC for reconstruction of the anterior spinal column following vertebrectomy for tumor (75 one-level, 19 two-level, 1 three-level). All patients underwent spinal stabilization as well. The median survival after surgery was 13.7 months; 23 patients had primary spinal tumors and 72 had metastatic tumors. Numerical pain scores were significantly improved postoperatively indicating a palliative benefit. No new neurological deficits were noted postoperatively, except when intentional neurological sacrifice was performed for oncologic reasons. Median height correction of 14% (range 0-118%) and median improvement in sagittal alignment of 6° (range 0-28°) were demonstrated on immediate postoperative imaging. Three patients experienced hardware related complications, one of which had posterior migration of the ETC. On postoperative imaging, 12 patients demonstrated subsidence of greater than 1 mm, but none required operative revision.
Use of an ETC for spinal reconstruction in patients with spinal tumors is safe, decreases pain associated with pathologic fracture, protects neurologic function, and is durable. We found a very low incidence of cage-related construct failures and no significant problems with subsidence.
为了治疗脊柱肿瘤,需要进行椎体切除术以重建脊柱的稳定性。由于癌症患者可能需要接受化疗和/或放疗,并且营养状况较差,这可能会影响骨骼质量,因此重建的耐久性可能是一个挑战。我们报告了一组在我院因原发性或转移性脊柱肿瘤接受椎体切除术并植入可扩张钛笼(ETC)进行重建的患者。我们报告了功能结果,评估了重建的耐久性,并描述了与该手术相关的并发症。
对我院因脊柱肿瘤接受椎体切除术并植入 ETC 进行重建的患者进行回顾性研究。
2001 年 9 月至 2006 年 8 月,95 例患者接受了 ETC 植入术,以重建肿瘤切除后的脊柱前柱(75 例为单节段,19 例为双节段,1 例为三节段)。所有患者均接受了脊柱稳定治疗。手术后中位生存时间为 13.7 个月;23 例患者为原发性脊柱肿瘤,72 例为转移性肿瘤。术后数字疼痛评分显著改善,表明具有姑息治疗效果。除了因肿瘤原因而进行的故意神经牺牲外,术后没有新的神经功能缺损。术后即刻影像学检查显示,中位数 14%的高度矫正(范围 0-118%)和中位数 6°的矢状位改善(范围 0-28°)。有 3 例患者发生与内固定相关的并发症,其中 1 例 ETC 发生后移。术后影像学检查发现 12 例患者的沉降大于 1mm,但均无需手术修正。
在脊柱肿瘤患者中使用 ETC 进行脊柱重建是安全的,可减轻与病理性骨折相关的疼痛,保护神经功能,且具有耐久性。我们发现笼相关结构失败的发生率非常低,沉降问题也不明显。